IL-11 facilitated lung cancer cell chemoresistance to cisplatin via the IL-11R/STAT3 signaling pathway by promoting activation of the anti-apoptotic proteins Bcl-2 and Survivin in lung adenocarcinoma [41]. Here, STAT3 is linked to lung adenocarcinoma.